Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centres.

Susanna Ranta,Jayashree Motwani,Jan Blatny, Martina Bührlen,Manuel Carcao,Hervé Chambost,Carmen Escuriola,Kathelijn Fischer,Mutlu Kartal-Kaess, Marloes de Kovel,Gili Kenet,Christoph Male,Beatrice Nolan,Roseline d'Oiron,Martin Olivieri,Ester Zapotocka,Nadine G Andersson,Christoph Königs

Haemophilia : the official journal of the World Federation of Hemophilia（2023）

引用 0|浏览11

暂无评分

摘要

Most centres choose to initiate prophylaxis with emicizumab before 12 months of age and without concomitant FVIII. In inhibitor patients, ITI is mostly given in addition to emicizumab, but there was no common practice on how to proceed after successful ITI.

查看译文

关键词

children, emicizumab, inhibitors, ITI, PUPs, survey

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要